ClinVar Miner

Submissions for variant NM_000384.3(APOB):c.10541C>T (p.Ala3514Val)

gnomAD frequency: 0.00003  dbSNP: rs1450324476
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000779746 SCV000916520 uncertain significance not specified 2018-03-12 criteria provided, single submitter clinical testing Variant summary: APOB c.10541C>T (p.Ala3514Val) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 121156 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.10541C>T in individuals affected with Familial Hypercholesterolemia and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance.
Invitae RCV002535661 SCV003255929 likely benign Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 2023-12-07 criteria provided, single submitter clinical testing
Ambry Genetics RCV003166066 SCV003862070 uncertain significance Cardiovascular phenotype 2023-02-12 criteria provided, single submitter clinical testing The p.A3514V variant (also known as c.10541C>T), located in coding exon 26 of the APOB gene, results from a C to T substitution at nucleotide position 10541. The alanine at codon 3514 is replaced by valine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.